Effectiveness of cognitive behaviour therapy on poststroke depression

Comparative evaluation of effectiveness of combined cognitive behaviour and drug therapy and drug therapy on poststroke depression

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201008214607N1

Enrollment

Registered

2010-10-10

Start date

2010-03-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive episode. Depressive episode

Interventions

Intervention 1: Citalopram, tablet 20-80 mg daily, once daily, for three months. Intervention 2: Citalopram, tablet 20-80 mg daily, once daily, for three months as well as Cognitive behaviour therapy

Treatment - Drugs

Behavior

Citalopram, tablet 20-80 mg daily, once daily, for three months

Citalopram, tablet 20-80 mg daily, once daily, for three months as well as Cognitive behaviour therapy included negative thoughts cognition and be conflict them, relaxation, pleasurable activity plann

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of post-stroke depression by neurologist and DSM IV-TR criteria, stroke clinical symptoms, findings of damage in brain CT scan or MRI Exclusion criteria: severe motor or sensory deficit, aphasia, loss of consciousness

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Poststroke depression. Timepoint: Before intervention, 8th week, end of intervention. Method of measurement: Beck depression test apply.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Danaie Sij

mdehghani@bums.ac.ir mdehghani44@yahoo.com+98 56 1444 8962

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026